The FDA's panel of independent advisors has plans to meet next month in order to discuss the Pfizer and Moderna COVID-19 vaccines for children under age 5, as well as the Novavax vaccine for adults. The Novavax vaccine is already approved in over three dozen countries worldwide, WebMD reports, including most of Europe. Head over to WebMD for everything we know on these important upcoming meetings.